One of the timeliest and, some say controversial, topics in clinical cardiac electrophysiology today is the proper role of the implantable cardioverter-defibrillator (ICD) in the treatment of patients ...

Please provide your email address to receive an email when new articles are posted on . Abbott announced that a cardiac resynchronization therapy defibrillator and an implantable cardioverter ...

Background: Although more than 150,000 implantable cardioverter defibrillators (ICDs) are implanted yearly worldwide, only few studies systematically examined complications of ICD therapy in large ...

Background Sudden cardiac death (SCD) is a common cause of cardiovascular mortality, often triggered by ventricular ...

A standard test of the implantable cardioverter defibrillator (ICD) is linked to significant thought-processing problems that improve for most patients within a year after the device is inserted, ...

There is a lower risk of 1-year ventricular arrhythmias or death in women with nonischemic cardiomyopathy and an implantable cardioverter defibrillator (ICD) compared with men.

Prophylactic implantable cardioverter defibrillator therapy did not reduce mortality in patients with a prior myocardial infarction, persistent moderate left ventricular systolic dysfunction and ...

A wearable automatic defibrillator may be an alternative to an implantable cardiac defibrillator for a small group of patients, say researchers. There are few large, randomized and controlled clinical ...

1 in 5 with implantable cardioverter-defibrillator don't meet criteria for use. Jan. 4, 2011— -- One in five patients who receive the heart-shocking, life-saving devices known as implantable ...

GlobalData's Medical Devices sector report, "Implantable Cardioverter Defibrillators (ICD) - Medical Devices Pipeline Assessment, 2017" provides an overview of Implantable Cardioverter Defibrillators ...